Regeneron Pharmaceuticals, Inc. logo REGN - Regeneron Pharmaceuticals, Inc.

Price: -- -- | CONSENSUS: Buy DETAILS
STRONG
BUY 0
BUY 32
HOLD 16
SELL 0
STRONG
SELL 0
| PRICE TARGET: $840.15 DETAILS
HIGH: $995.00
LOW: $641.00
MEDIAN: $857.50
CONSENSUS: $840.15
UPSIDE: 31.50%

Profitability Ratios

Ratio Value
GP Margin 85.4%
EBIT Margin 36.8%
EBITDA Margin 40.6%
Operating Margin 24.9%
Pretax Margin 36.5%
Cont. Ops Margin 31.4%
Net Margin 31.4%
Bottom Line Margin 31.4%

Liquidity Ratios

Ratio Value
Current Ratio 4.13
Quick Ratio 3.39
Solvency Ratio 0.543
Cash Ratio 0.71

Valuation Ratios

Ratio Value
Price/Earnings
17.92
Hist. avg: 39.3
Peers avg: 28.1
PEG Ratio 3.38
Forward PEG 3.38
Price/Book 2.58
Price/Sales 5.63
Price/FCF 19.79
Price/Op Cash Flow 16.22

Debt Ratios

Ratio Value
Debt/Assets 0.0667
Debt/Equity 0.0866
Debt/Capital 0.0797
Long-Term Debt/Capital 0.0597
Financial Leverage 1.30

Cash Flow Ratios

Ratio Value
Working Capital Turnover 1.01
Operating Cash Flow Ratio 1.140
Operating Cash Flow/Sales 34.7%
Free Cash Flow/Operating Cash Flow 82.0%

Coverage Ratios

Ratio Value
Debt Service Coverage 116.26
Interest Coverage 81.6872
Short-Term Operating Cash Flow Coverage 0.00
Operating Cash Flow Coverage 1.84
Capital Expenditure Coverage 5.54
Dividend + Capital Expenditure Coverage 3.92

Dividend Ratios

Ratio Value
Payout Ratio 8.2199%
Dividend Yield 0.4586%
Dividend Yield % 0.4586%
Dividend Per Share 3.5402

Per Share Ratios

Ratio Value
Revenue/Share 137.12
EPS 43.068
Debt/Share 26.2878
Cash/Share 82.27
Book Value/Share 298.82
Tangible BV/Share 286.80
Equity/Share 298.82
Operating Cash Flow/Share 47.599
Capital Expenditure/Share 8.589
FCF/Share 39.011

Other Ratios

Ratio Value
Net Income/Earnings Before Tax 0.861
Earnings Before Tax/EBIT 1.462
Price/Fair Value 2.58
Debt/Market Cap 0.0246
Effective Tax Rate 13.9%
Enterprise Value Multiple 13.81